Inspire Medical Systems Receivables 2017-2024 | INSP

Inspire Medical Systems receivables from 2017 to 2024. Receivables can be defined as the total amount of collectibles for a company
  • Inspire Medical Systems receivables for the quarter ending September 30, 2024 were $0.090B, a 25.58% increase year-over-year.
  • Inspire Medical Systems receivables for 2023 were $0.09B, a 46.8% increase from 2022.
  • Inspire Medical Systems receivables for 2022 were $0.061B, a 79.14% increase from 2021.
  • Inspire Medical Systems receivables for 2021 were $0.034B, a 36.37% increase from 2020.
Inspire Medical Systems Annual Receivables
(Millions of US $)
2023 $90
2022 $61
2021 $34
2020 $25
2019 $13
2018 $7
2017 $4
2016 $
Inspire Medical Systems Quarterly Receivables
(Millions of US $)
2024-09-30 $90
2024-06-30 $80
2024-03-31 $72
2023-12-31 $90
2023-09-30 $71
2023-06-30 $64
2023-03-31 $60
2022-12-31 $61
2022-09-30 $48
2022-06-30 $40
2022-03-31 $35
2021-12-31 $34
2021-09-30 $27
2021-06-30 $25
2021-03-31 $22
2020-12-31 $25
2020-09-30 $21
2020-06-30 $10
2020-03-31 $11
2019-12-31 $13
2019-09-30 $11
2019-06-30 $9
2019-03-31 $7
2018-12-31 $7
2018-09-30 $5
2018-06-30 $4
2018-03-31 $3
2017-12-31 $4
2017-09-30
2017-06-30
2017-03-31
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.892B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.384B 0.00
Hims & Hers Health (HIMS) United States $5.028B 130.06
Axonics (AXNX) United States $3.600B 1760.50
IRhythm Technologies (IRTC) United States $2.707B 0.00
Enovis (ENOV) United States $2.594B 17.58
Privia Health (PRVA) United States $2.547B 213.00
Omnicell (OMCL) United States $2.306B 75.97
Azenta (AZTA) United States $2.190B 124.39
10x Genomics (TXG) United States $1.893B 0.00
Clover Health Investments (CLOV) United States $1.696B 0.00
Schrodinger (SDGR) United States $1.365B 0.00
Phreesia (PHR) United States $1.228B 0.00
Standard BioTools (LAB) United States $0.800B 0.00
Fulgent Genetics (FLGT) United States $0.589B 0.00
Butterfly Network (BFLY) United States $0.558B 0.00
Talkspace (TALK) United States $0.555B 0.00
Definitive Healthcare (DH) United States $0.500B 84.80
Health Catalyst (HCAT) United States $0.498B 0.00
Pulmonx (LUNG) United States $0.294B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.230B 0.00
TruBridge (TBRG) United States $0.203B 58.91
American Well (AMWL) United States $0.135B 0.00
P3 Health Partners (PIII) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.108B 0.00
HeartBeam (BEAT) United States $0.068B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
111 (YI) China $0.059B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
SHL Telemedicine (SHLT) Israel $0.045B 0.00
CareCloud (CCLD) United States $0.044B 0.00
Outset Medical (OM) United States $0.040B 0.00
Movano (MOVE) United States $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00